HighTide Therapeutics, Inc. (HKG:2511)
Hong Kong · Delayed Price · Currency is HKD 4.160
+0.140 (3.48%)
May 7, 2026, 4:08 PM HKT
HighTide Therapeutics Market Cap
HighTide Therapeutics has a market cap or net worth of 2.3 billion as of May 7, 2026. Its market cap has increased by 235.46% in one year.
Market Cap
2.30B
Enterprise Value
1.94B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4.16
Market Cap Chart
Since December 22, 2023, HighTide Therapeutics's market cap has decreased from 6.37B to 2.30B, a decrease of -63.96%. That is a compound annual growth rate of -34.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 2.30B | 36.27% |
| Dec 31, 2025 | 1.69B | 157.80% |
| Dec 31, 2024 | 653.76M | -90.20% |
| Dec 29, 2023 | 6.67B | 4.68% |
| Dec 22, 2023 | 6.37B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Antengene Corporation | 3.23B |
| Jiangsu Recbio Technology | 3.20B |
| Medtide | 3.11B |
| AIM Vaccine | 2.92B |
| Frontage Holdings | 2.01B |
| SinoMab BioScience | 1.96B |
| Mabpharm | 1.86B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.85B |